You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 27, 2024

CALCIUM DISODIUM VERSENATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Calcium Disodium Versenate, and when can generic versions of Calcium Disodium Versenate launch?

Calcium Disodium Versenate is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in CALCIUM DISODIUM VERSENATE is edetate calcium disodium. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the edetate calcium disodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Calcium Disodium Versenate

A generic version of CALCIUM DISODIUM VERSENATE was approved as edetate calcium disodium by CASPER PHARMA LLC on May 3rd, 2023.

  Try a Trial

Summary for CALCIUM DISODIUM VERSENATE
Drug patent expirations by year for CALCIUM DISODIUM VERSENATE
Drug Prices for CALCIUM DISODIUM VERSENATE

See drug prices for CALCIUM DISODIUM VERSENATE

Recent Clinical Trials for CALCIUM DISODIUM VERSENATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
M.D. Anderson Cancer CenterPhase 1
National Cancer Institute (NCI)Phase 1
Mt. Sinai Medical Center, MiamiPhase 4

See all CALCIUM DISODIUM VERSENATE clinical trials

US Patents and Regulatory Information for CALCIUM DISODIUM VERSENATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch CALCIUM DISODIUM VERSENATE edetate calcium disodium INJECTABLE;INJECTION 008922-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bausch CALCIUM DISODIUM VERSENATE edetate calcium disodium TABLET;ORAL 008922-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.